Clinical Trials
11 trialsNCT01384513 2026-04-15
A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies
Thomas Jefferson University
Phase 2 Completed
NCT00255346 2025-12-30
Dasatinib as Therapy for Myeloproliferative Disorders (MPDs)
M.D. Anderson Cancer Center
Phase 2 Completed
NCT06432556 2024-05-29
MastCellHet
University Hospital, Toulouse
Phase NA Not yet recruiting
NCT00038675 2022-01-04
Therapy of HES, PV, Atypical Chronic Myelocytic Leukemia (CML) or Chronic Myelomonocytic Leukemia (CMML), and Mastocytosis With Imatinib Mesylate
M.D. Anderson Cancer Center
Phase NA Completed
NCT05084872 2021-10-20
HCQMa
University Hospital, Toulouse
Phase 2/3 Unknown
NCT03340155 2017-11-13
BioUV2017
Medical University of Graz
Phase NA Unknown
NCT01481909 2016-11-03
SMART
Charite University, Berlin, Germany
Phase 2/3 Completed
NCT01297777 2016-08-29
Imatinib in KIT-negative Systemic Mastocytosis
Hospital Virgen de la Salud
Phase 4 Completed
NCT01602939 2016-08-29
Cladribine Plus Pegylated Interpheron Alfa-2a in Systemic Mastocytosis
Hospital Virgen de la Salud
Phase 2/3 Unknown
NCT01333293 2016-01-18
XOLMA
University of Zurich
Phase 2/3 Completed
NCT01920204 2015-01-19
Midostaurin in Indolent Systemic Mastocytosis
University Medical Center Groningen
Phase 2 Unknown